Latest Conference Articles

Researcher speaks on his team's findings regarding uveitis candidate sirolimus.

Eye conditions help explain uptick in collisions.

"I’ve been going to ARVO for 20 years...every year I learn a lot,” Loewenstein says.

$100,000 award for up to 3 winners in a race to grow the best artifical retinas.

The biggest unmet need nowadays in retina disease is geographic atrophy..."

It does show that there is a difference between the drugs,” she says.

$1 million is up for grabs

Babies exposed to marijuana in the womb may require clinical care sooner.

Patients in tocilizumab treatment group 4 times more likely to see remission.

With many manifestations, giant cell arteritis must be addressed across specialties.

Retinal cell replacement counters effects of glaucoma in lab settings.

Algorithm able to correctly predict drusen progression with encouraging accuracy.

The Synthroid brand of levothyroxine improved thyroid-stimulating hormone (TSH) levels by a significantly greater margin compared with generic versions of the synthetic T4 (LT4) hormones for patients with hypothyroidism.

At AACE 2017, John Bilezikian, MD, discussed the latest FDA approval of Tymlos for postmenopausal women with osteoporosis and for women who are at high risk for fracture.

According to Kathleen “Kittie” Wyne, MD, PhD, The Ohio State University, in the identification and treatment of hypothyroidism, people need to be aware that the symptoms associated with hypothyroidism can be non-specific.

At AACE 2017, Kathleen “Kittie” Wyne, MD, PhD, The Ohio State University, discussed new data on hypothyroidism. Although hypothyroidism requires lifelong adherence to therapy, compliance still remains challenging.

More than 25% of the US population over the age of 65 has diabetes.

At AACE 2017, Jagdeesh Ullal, MD, MS, Eastern Virginia Medical School discussed data from his team’s study that assessed the efficacy of an electronic glycemic management system (eGlycemic Management) management in controlling blood sugars in the hospital setting.

“Treatment of diabetic foot ulcers depends upon the severity of the infection,” said Andrew Boulton, MD, University of Manchester, UK, University of Miami, Florida at AACE 2017.

According to Andrew Boulton, MD, University of Manchester, UK, University of Miami, Florida, the most important take home message for doctors regarding the diabetic foot and reducing amputations, is to remove their patients’ shoes and socks and look at their feet.

Heart failure is diabetes’ most sinister, most overlooked complication

AACE speakers on the challenge of managing patients’ adrenal conditions

Peter Goadsby, M.B., B.S., Director of the NIHR- Wellcome Trust King’s Clinical Research, London, Professor of Neurology, University of California at San Francisco, explained the benefits of the recent FDA approval of the gammaCore non-invasive vagal nerve stimulator on patients suffering from cluster headaches.

At AACE 2017, Shashank Joshi, MD, Lilavati Hospital and Research Centre, Mumbai explained his team’s simple diabetes treatment formula: A for A1C, B for blood pressure, C for cholesterol (LDL cholesterol), and D for diet that’s culturally sensitive and adaptable.

Shashank Joshi, MD, Lilavati Hospital and Research Centre, Mumbai, spoke to MD Magazine about the cultural considerations when attempting to personalize diabetes care.

Somatropin increased HDL-C levels in patients with GHD at 24 months.

A new category of cardiovascular “extreme risk” has LDL-C goals of

In terms of specific endocrine functions, bones favor glucose metabolism and homeostasis and are necessary for memory formation and for muscle function during exercise. Gerard Karsenty, MD, PhD also explained that osteo-calcium is not only necessary to foster this function, but it’s also sufficient, and can improve this function in animals.

More research and education could to prevent inherent risks

Andres Kanner, MD, Professor of Clinical Neurology, Chief of Epilepsy Division from the University of Miami Miller School of Medicine addressed that there were several medications in the pipeline being tested for different aspects of epilepsy treatment.